Ben-Gurion University researchers slash pre-drug screening time from years to days

(American Associates, Ben-Gurion University of the Negev) 'Our new approach will increase the understanding of the mechanisms and evolutionary origins of specific PPIs, and facilitate the rational design of specific inhibitors that can discriminate between structurally similar protein targets,' says Professor Niv Papo of BGU's Avram and Stella Goldstein-Goren Department of Biotechnology Engineering and the National Institute for Biotechnology in the Negev (NIBN).